Novel Coronavirus (SARS-CoV-2/COVID-19)
Other Events This Week Include HHS Webinars on COVID-19 Data Reporting and AHA Leadership Rounds with AHA Chair Dr. Estes
In 2019, the term 鈥渂urnout鈥 was added to the World Health Organization鈥檚 International Classification of Diseases (ICD). According to the ICD, burnout is a 鈥渟yndrome conceptualized as resulting from chronic workplace stress that has not been successfully managed.鈥
The AABB, America鈥檚 Blood Centers and the American Red Cross urged eligible individuals to donate blood, calling the nation鈥檚 blood supply 鈥渃ritically low.鈥
A new analysis by Global Health 50/50, an initiative to advance gender equality in global health, sheds light on sex disparities in COVID-19 deaths.
The Department of Health and Human Services announced the new option of saliva tests at federal community-based testing sites in areas experiencing COVID-19 surge.
Jim Skogsbergh, president and CEO of Advocate Aurora Health, will join AHA Board Chair Melinda Estes, M.D., Oct. 22 at 3:30 p.m. ET to discuss COVID-19鈥檚 impact on health trends and key strategies for reimagining and innovating care during and beyond the pandemic.
Hear several organizations describe their programs to address patients' unmet legal needs and鈥痟ow COVID-19鈥痟as shaped the focus of medical-legal partnerships.
COVID-19 is a pandemic with no precedent, and certainly no equal. In many ways, we鈥檝e been learning as we go. For health care professionals, this has elevated the importance of peer-to-peer sharing as never before.
A recent article on hospital field finances ignores the diverse experiences of hospitals during the pandemic, particularly those under significant financial pressure, writes Aaron Wesolowski, AHA鈥檚 vice president of policy research, analytics and strategy.
The National Institutes of Health announced the start of an adaptive phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.